{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:16Z","timestamp":1786118896490,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/wco.0b013e32830dd5a6","type":"journal-article","created":{"date-parts":[[2008,9,3]],"date-time":"2008-09-03T07:04:35Z","timestamp":1220425475000},"page":"601-606","source":"Crossref","is-referenced-by-count":67,"title":["Lipid storage myopathies"],"prefix":"10.1097","volume":"21","author":[{"given":"Claudio","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"DiMauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210206","first-page":"1587","article-title":"Disorders of lipid metabolism","author":"Di Donato","year":"2004"},{"key":"R2-15-20210206","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142","author":"Longo","year":"2006","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R3-15-20210206","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/humu.20314","article-title":"Pharmacological rescue of carnitine transport in primary carnitine deficiency","volume":"27","author":"Amat di San Filippo","year":"2006","journal-title":"Hum Mutat"},{"key":"R4-15-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.182.4115.929","article-title":"Muscle carnitine palmityltransferase deficiency and myoglobinuria","volume":"182","author":"DiMauro","year":"1973","journal-title":"Science"},{"key":"R5-15-20210206","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"R6-15-20210206","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.20320","article-title":"Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations","volume":"57","author":"\u00d8rngreen","year":"2005","journal-title":"Ann Neurol"},{"key":"R7-15-20210206","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","article-title":"Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency","volume":"89","author":"Isackson","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R8-15-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2007.09.015","article-title":"Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency","volume":"266","author":"Corti","year":"2008","journal-title":"J Neurol Sci"},{"key":"R9-15-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Arch Neurol"},{"key":"R10-15-20210206","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1399-0004.2008.00986.x","article-title":"Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency","volume":"73","author":"Yasuno","year":"2008","journal-title":"Clin Genet"},{"key":"R11-15-20210206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.str.2006.01.008","article-title":"The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment","volume":"14","author":"Rufer","year":"2006","journal-title":"Structure"},{"key":"R12-15-20210206","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bbrc.2006.06.006","article-title":"Crystal structure of rat carnitine palmitoyltransferase II (CPT- II)","volume":"346","author":"Hsiao","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-15-20210206","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/01.WNL.0000130486.54839.15","article-title":"A new diagnostic test for VLCAD deficiency using immunohistochemistry","volume":"62","author":"Ohashi","year":"2004","journal-title":"Neurology"},{"key":"R14-15-20210206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjmed.2005.07.064","article-title":"Rhabdomyolysis caused by an inherited metabolic disease: very long-chain acyl-CoA dehydrogenase deficiency","volume":"119","author":"Voermans","year":"2006","journal-title":"Am J Med"},{"key":"R15-15-20210206","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7205\/MILMED.171.7.657","article-title":"Rhabdomyolysis in the military: recognizing late-onset very long-chain acyl Co-A dehydrogenase deficiency","volume":"171","author":"Hoffman","year":"2006","journal-title":"Mil Med"},{"key":"R16-15-20210206","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/01.wnl.0000265854.41013.84","article-title":"Effects of IV glucose and oral medium-chain triglyceride in patients with VLCAD deficiency","volume":"69","author":"\u00d8rngreen","year":"2007","journal-title":"Neurology"},{"key":"R17-15-20210206","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.nmd.2005.09.003","article-title":"The effect of dantrolene sodium in very long chain acyl-CoA dehydrogenase deficiency","volume":"15","author":"Voermans","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R19-15-20210206","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1210\/jc.2004-1936","article-title":"Peroxisome proliferator activated receptor \u03b4 (PPAR\u03b4) agonist but not PPAR\u03b1 corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells","volume":"90","author":"Djouadi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-15-20210206","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/hmg\/ddi303","article-title":"Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders","volume":"14","author":"Djouadi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R21-15-20210206","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/522375","article-title":"Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy","volume":"81","author":"Gobin-Limballe","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R22-15-20210206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2006.02.010","article-title":"In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase","volume":"88","author":"Merritt","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R23-15-20210206","first-page":"2297","article-title":"Mitochondrial fatty acid oxidation disorders","author":"Roe","year":"2001"},{"key":"R24-15-20210206","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2007.09.021","article-title":"Short-chain acyl-CoA dehydrogenase gene mutation (c.319C>T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin","volume":"93","author":"Tein","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R25-15-20210206","first-page":"2357","article-title":"Defects of electron transfer flavoprotein and electron transfer flavoprotein ubiquinone oxidoreductase: glutaric acidemia type II","author":"Frerman","year":"2001"},{"key":"R26-15-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2006.01.009","article-title":"Electron transfer flavoprotein deficiency: functional and molecular aspects","volume":"88","author":"Schiff","year":"2006","journal-title":"Mol Genet Metab"},{"key":"R27-15-20210206","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/brain\/awm135","article-title":"ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency","volume":"130","author":"Olsen","year":"2007","journal-title":"Brain"},{"key":"R28-15-20210206","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/brain\/awm054","article-title":"The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene","volume":"130","author":"Gempel","year":"2007","journal-title":"Brain"},{"key":"R29-15-20210206","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000194241.35115.7c","article-title":"Coenzyme Q10 deficiency and isolated myopathy","volume":"66","author":"Horvath","year":"2006","journal-title":"Neurology"},{"key":"R30-15-20210206","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"R31-15-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin\u2013Dorfman Syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab"},{"key":"R32-15-20210206","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/324121","article-title":"Mutations in CGI-58, the gene encoding a new protein of the esterase\/lipase\/thioesterase subfamily, in Chanarin\u2013Dorfman syndrome","volume":"69","author":"Lef\u00e8vre","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R33-15-20210206","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.jid.5700332","article-title":"Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin\u2013Dorfman syndrome)","volume":"126","author":"Demerjian","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R34-15-20210206","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbrc.2008.03.010","article-title":"Clinical and genetic characterization of Chanarin\u2013Dorfman syndrome","volume":"369","author":"Bruno","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R35-15-20210206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"key":"R36-15-20210206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/mus.20869","article-title":"Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy","volume":"36","author":"Akiyama","year":"2007","journal-title":"Muscle Nerve"},{"key":"R37-15-20210206","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1210\/jc.2007-2247","article-title":"The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets","volume":"93","author":"Kobayashi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-15-20210206","doi-asserted-by":"crossref","first-page":"17211","DOI":"10.1074\/jbc.M710566200","article-title":"The C-terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding","volume":"283","author":"Schweiger","year":"2008","journal-title":"J Biol Chem"},{"key":"R39-15-20210206","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e32830dd5a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:39Z","timestamp":1786035879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200810000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32830dd5a6","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}